IL10-related pathway is associated with acute graft-versus-host disease after haematopoietic stem cell transplantation

被引:0
|
作者
Turpeinen, H.
Sivula, J.
Volin, L.
Partanen, J.
机构
[1] Finnish Red Cross Blood Serv, Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Div Hematol, Dept Med, Helsinki, Finland
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:619 / 619
页数:1
相关论文
共 50 条
  • [1] Acute graft-versus-host disease and thymic function after haematopoietic stem cell transplantation in human
    Clave, E.
    Busson, M.
    Douay, C.
    de Latour, R. Peffault
    Carmagnat, M.
    Rabian, C.
    Charron, D.
    Socie, G.
    Toubert, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S222 - S223
  • [2] Elafin for fast diagnosis of acute graft-versus-host disease of the skin after haematopoietic stem cell transplantation
    Calkoen, F. G. J.
    Jol-van der Zijde, C. M.
    Wortel, C.
    Jansen-Hoogendijk, A.
    Santos-Boei, S.
    van Halteren, A. G. S.
    Ball, L. M.
    van Tol, M. J. D.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S170 - S171
  • [3] Effect of acute graft-versus-host disease on the overall survival after allogeneic haematopoietic stem cell transplantation
    Pevna, M.
    Krejci, M.
    Coupek, P.
    Klabusay, M.
    Mayer, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S144 - S145
  • [4] Proteomic patterns predict acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
    Weissinger, E. M.
    Schiffer, E.
    Hertenstein, B.
    Holler, E.
    Ferrara, J. L.
    Kolb, H. J.
    Zander, A.
    Zurbig, P.
    Kellmann, M.
    Ganser, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S22 - S22
  • [5] Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease
    S Kulkarni
    R Powles
    B Sirohi
    J Treleaven
    R Saso
    C Horton
    A Atra
    M Ortin
    C Rudin
    S Goyal
    S Sankpal
    S Meller
    C R Pinkerton
    J Mehta
    S Singhal
    Bone Marrow Transplantation, 2003, 32 : 165 - 170
  • [6] Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease
    Kulkarni, S
    Powles, R
    Sirohi, B
    Treleaven, J
    Saso, R
    Horton, C
    Atra, A
    Ortin, M
    Rudin, C
    Goyal, S
    Sankpal, S
    Meller, S
    Pinkerton, CR
    Mehta, J
    Singhal, S
    BONE MARROW TRANSPLANTATION, 2003, 32 (02) : 165 - 170
  • [7] KIR/HLA interactions and acute graft-versus-host disease in haematopoietic stem cell transplantation
    Luclajic, K.
    Balavarca, Y.
    Bickebller, H.
    Pohlreich, D.
    Kouba, M.
    Kalhs, P.
    Greinix, H. T.
    Fae, I.
    Fischer, G. F.
    TISSUE ANTIGENS, 2008, 71 (04): : 280 - 281
  • [8] Proteomic patterns and graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
    Chiusolo, P.
    Bellesi, S.
    Fanali, C.
    Giammarco, S.
    Sica, S.
    Inzitari, R.
    Iavarone, F.
    Leone, G.
    Castagnola, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S13 - S13
  • [9] Graft-versus-host disease is associated with a lower relapse incidence after haematopoietic stem cell transplantation in patients with acute lymphoblastic leukaemia
    Nordlander, A
    Mattsson, J
    Ringden, O
    Le Blanc, K
    Gustavsson, B
    Ljungman, P
    Svenberg, P
    Svennilson, J
    Remberger, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S187 - S187
  • [10] Computed tomography imaging of acute gastrointestinal graft-versus-host disease after haematopoietic stem cell transplantation in children
    Arpaci, Taner
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2018, 22 (03): : 178 - 183